VAXICAN Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
IPO
- (Upcoming)
- Investors
-
6
VAXICAN General Information
Description
Developer of therapeutic cancer vaccines designed to strengthen the body's immune response against cancer. The company offers enveloped virus-like particle-based vaccines supported by proprietary machine learning and artificial intelligence technologies, enabling biotechnology companies, research organizations, and healthcare providers to develop immunotherapies for cancer.
Contact Information
Website
www.vaxican.comCorporate Office
- Ul. Kampinoska 25
- Gdańsk, 80-180
- Poland
Corporate Office
- Ul. Kampinoska 25
- Gdańsk, 80-180
- Poland
VAXICAN Timeline
VAXICAN Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. IPO | 01-Jun-2028 | Upcoming | Pre-Clinical Trials | |||
| 5. Later Stage VC (Series A) | 01-Jun-2027 | Upcoming | Pre-Clinical Trials | |||
| 4. Later Stage VC | 23-Sep-2026 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 19-Nov-2025 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 30-Oct-2020 | $900K | $900K | Completed | Pre-Clinical Trials | |
| 1. University Spin-Out | 01-Jan-2019 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
VAXICAN Comparisons
Industry
Financing
Details
VAXICAN Competitors (6)
One of VAXICAN’s 6 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| BioNTech | Formerly VC-backed | Mainz, Germany | ||||
| Moderna | Formerly VC-backed | Cambridge, MA | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Bavarian Nordic | Corporation | Hellerup, Denmark |
VAXICAN Signals
VAXICAN Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Voolt | Corporation | Minority | ||
| DeepTech Capital Consortium | Angel Group | Minority | ||
| iif.vc | Venture Capital | Minority | ||
| Rubicon Partners (Warsaw) | Venture Capital | Minority | ||
| StartSmart CEE | Accelerator/Incubator |
VAXICAN FAQs
-
When was VAXICAN founded?
VAXICAN was founded in 2019.
-
Where is VAXICAN headquartered?
VAXICAN is headquartered in Gdańsk, Poland.
-
What is the size of VAXICAN?
VAXICAN has 20 total employees.
-
What industry is VAXICAN in?
VAXICAN’s primary industry is Drug Discovery.
-
Is VAXICAN a private or public company?
VAXICAN is a Private company.
-
What is VAXICAN’s current revenue?
The current revenue for VAXICAN is .
-
How much funding has VAXICAN raised over time?
VAXICAN has raised $6.95M.
-
Who are VAXICAN’s investors?
Voolt, DeepTech Capital Consortium, iif.vc, Rubicon Partners (Warsaw), and StartSmart CEE are 5 of 6 investors who have invested in VAXICAN.
-
Who are VAXICAN’s competitors?
Genentech, BioNTech, Moderna, Merck & Co., and Bavarian Nordic are some of the 6 competitors of VAXICAN.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process